Cerca
Psychoactive Substances
Psychoactive substances are natural or synthetic substances that act on the central nervous system and alter mental processes such as mood, perception, cognition, consciousness, and behaviour. These substances may be legally prescribed medications (e.g., pain medications or sedatives), legally available substances such as alcohol or caffeine, or controlled or illicit drugs. Psychoactive substances can be used for medical, social, cultural, or recreational purposes, but some carry risks of misuse, dependence, and health or social harms when used in harmful ways.
Bilancio di un decennio di politiche in materia di droga: progressi e sfide
Introduzione Secondo l'ultimo Rapporto Mondiale sulla Droga pubblicato dall'Ufficio delle Nazioni Unite contro la Droga e il Crimine (UNODC) per l'anno 2022, circa 284 milioni di persone di età compresa tra i 15 e i 64 anni hanno fatto uso di droghe.
WHO stakeholder survey on improving access to morphine for medical use
WHO launched a survey on assessing barriers, enablers, and pirority actions for improving access to morphine for medical use.
All Civil Society Organisation can contribute by filling out the survey before 31 August 2022.
The survey is...
Лекция 1: Центральноазиатский цикл открытых лекций по скринингу, оценке и лечению расстройств, связанных с употреблением психоактивных веществ
Открытые лекции будут проводиться по совместной инициативе ISSUP Ukraine, ISSUP Kazakhstan и ITTC Ukraine.
Национальный круглый стол по завершенному исследованию распространенности новых психоактивных веществ
Приглашаем специалистов Министерства здравоохранения РК, Министерства внутренних дел РК, Казахского научного центра дерматологии и инфекционных заболеваний, представителей UNODC, UNAIDS, неправительственных организаций, руководителей и врачей региональных Центров психического здоровья.
Migliorare l'equità e l'accesso al trattamento con buprenorfina attraverso la telemedicina nei programmi di servizi di siringa
Sfondo
Negli Stati Uniti, l'accesso alla buprenorfina rimane basso e sono emerse disparità riguardo a chi riceve il trattamento. Le leggi federali hanno regolamentato la somministrazione di buprenorfina, limitandone in ultima analisi l...
The effects of opioid policy changes on transitions from prescription opioids to heroin, fentanyl and injection drug use: a qualitative analysis
Background
Beginning in the 1990s, non-medical use of prescription opioids (POs) became a major public health crisis. In response to rising rates of opioid dependence and fatal poisonings, measures were instituted to decrease the...
Addressing drug challenges in health and humanitarian crises: Settings in need of care for a comprehensive drug use prevention in Nigeria
Paper presented at the commemoration of the 2022 International Day Against Drug Abuse & Illicit Trafficking, State House Conference Centre, Abuja, Nigeria.
The UNODC/PTRS demand reduction mentor at the UNODC Programme Office in Indonesia provided technical assistance to the National Narcotics Board (BNN) in conducting a national hybrid training for Government Officials on the UNODC Treatnet Family programme
On July 19th, 2022, the Director of Strengthening Government Institution, Deputy of Rehabilitation, BNN officially launched a national hybrid training on the UNODC Treatnet Family programme with 34 representatives from all BNN provinces and...
Webinar bimestrale: Serie di aggiornamento delle conoscenze ISSUP Nigeria (tredicesima sessione)
ISSUP Nigeria vorrebbe invitarti a partecipare al loro prossimo webinar bimestrale nella serie di aggiornamento delle conoscenze. L'argomento del webinar sarà Oltre la dipendenza: disturbi indotti dall'alcol.
Obiettivi formativi:
• Sen...
Measurement of Striatal Dopamine Release Induced by Neuropsychological Stimulation in Positron Emission Tomography With Dual Injections of [11C]Raclopride
Objectives: Positron emission tomography (PET) with [11C]raclopride has been applied to measure changes in the concentration of endogenous dopamine induced by pharmacological challenge or neuropsychological stimulation by evaluating the...
Treating co-occurring substance use and mental health disorders using tools from CBT
Presented by Jo Cassar (The Matilda Centre for Research in Mental Health and Substance Use, University of Sydney), by the end of this webinar, attendees will be able to:
- Recognise the importance of assessing for substance use when a...
Eating disorders and AOD use: what clinicians need to know
Presented by Associate Professor Sarah Maguire (Director, InsideOut Institute), by attending this webinar, attendees will learn:
- How to recognise the most common eating disorder symptoms;
- Eating disorder interventions and how workers...
Kenya to include smoking cessation drugs as essential medicines
The Ministry of Health has been advised to add two non-nicotine drugs to Kenya’s Essential Medicines List, to help smokers quit tobacco and nicotine addiction.
The World Health Organization said the two drugs bring “a powerful shift in the...
Multiple disadvantage and co-occurring substance use and mental health conditions.
Substance use and mental health needs are two of the primary concerns for many people experiencing multiple disadvantage. We know that people who experience both issues at the same time (also known as “co-occurring conditions” or “dual...
L'impatto della discriminazione sui disturbi da uso di sostanze tra le minoranze sessuali
Questo documento mirava a rivedere la letteratura riguardante l'impatto della discriminazione sui disturbi da uso di sostanze tra le minoranze sessuali, con particolare attenzione ad alcol, oppioidi, stimolanti, policonsumo di droghe...
L'Ecolink Institute inaugura la formazione UTC in hindi
L'Ecolink Institute avvia la formazione UTC in hindi
Mangalore: Dal 6 luglio 2022 l'Ecolink Institute of well-being, con sede a Mangalore, un fornitore di formazione approvato dal Piano Colombo, ha avviato una formazione speciale su...
Nuove sostanze psicoattive (NPS) - la situazione irlandese.
La presente scheda informativa riassume le informazioni e le statistiche sulle nuove sostanze psicoattive raccolte dalle recenti relazioni sulla prevalenza, il trattamento, la mortalità e la legislazione in Irlanda.
The cardiovascular risks and benefits of quit smoking medicines
In this presentation, the speakers reported the results of a series of three population-based cohort studies relating to the use and effects of smoking cessation pharmacotherapies. The first of these studies provided evidence on how the...
World Drug Report 2022
The 2022 World Drug Report provides a global overview of the supply and demand of opiates, cocaine, cannabis, amphetamine-type stimulants and new psychoactive substances (NPS), as well as their impact on health.
Association of Prenatal Exposure to Maternal Drinking and Smoking With the Risk of Stillbirth
Abstract
Importance Prenatal smoking is a known modifiable risk factor for stillbirth; however, the contribution of prenatal drinking or the combination of smoking and drinking is uncertain.
Objective To examine whether prenatal...